Anti-mGluR2 conformational single domain antibodies and uses thereof
US10174115B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 3, 2015 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Jul 3, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibodies and uses thereof in particular in the therapeutic and diagnostic field.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.